Kristen Overly

kristen headshot.jpg

Kristen Overly is a junior in Biological Engineering at MIT interested in the business strategy and cross-border financing of biotech companies. She currently serves as the Undergraduate President of the MIT Biotech Group (MBG). She has been involved in MBG's Investment Initiative since 2017 and also consulted for Remora Therapeutics on business development activities in oncology. Kristen performed strategic analyses for Back Bay Life Science Advisors as a summer analyst and will join JPMorgan Chase’s Healthcare Equity Capital Markets team in San Francisco next summer.